Cargando…
COMPLEMENT-DERIVED LEUKOTACTIC FACTORS IN PATHOLOGICAL FLUIDS
Leukotactic factors derived from the complement sequence consist of C5-related products, including the small cleavage product and the higher molecular weight complex (C567). A leukotactically active cleavage product (of low molecular weight) has also been described. The C5-related factors have been...
Autor principal: | Ward, Peter A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1971
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139064/ https://www.ncbi.nlm.nih.gov/pubmed/19867360 |
Ejemplares similares
-
THE C3-ACTIVATOR SYSTEM: AN ALTERNATE PATHWAY OF COMPLEMENT ACTIVATION
por: Götze, Otto, et al.
Publicado: (1971) -
INTERACTION OF CELLS WITH IMMUNE COMPLEXES: ADHERENCE, RELEASE OF CONSTITUENTS, AND TISSUE INJURY
por: Henson, Peter M.
Publicado: (1971) -
MECHANISMS OF LYSOSOMAL ENZYME RELEASE FROM LEUKOCYTES EXPOSED TO IMMUNE COMPLEXES AND OTHER PARTICLES
por: Weissmann, Gerald, et al.
Publicado: (1971) -
IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW-REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG : I. MODULATION BY AGENTS INFLUENCING CELLULAR LEVELS OF CYCLIC 3',5'-ADENOSINE MONOPHOSPHATE
por: Orange, Robert P., et al.
Publicado: (1971) -
MECHANISMS INVOLVED IN THE DEPOSITION OF IMMUNE COMPLEXES IN TISSUES
por: Cochrane, Charles G.
Publicado: (1971)